Genebeyond®  is a research and development company focusing on new drug discovery and development, especially on cancer immunotherapy and tissue regeneration. Our biopharmaceutical platforms include monoclonal antibody discovery and design, biologics processes development and scale-up,  synthetic biology, small molecule discovery, etc.  Genebeyond® also provides technical support in deciphering physiological functions and related diseases, new biomarker and  drug target identification and validation  such as cell surface receptors, enzymes, GPCRs, ion channels, protein complexes, cell-cell interactions, etc.